Stay updated on SL-401 Combo in AML/MDS/BPDCN Clinical Trial

Sign up to get notified when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-30T04:49:46.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:08:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-05-08T13:50:21.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.7%
    Check dated 2025-05-01T06:13:25.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-23T23:14:32.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the clinical trial information, including the addition of collaborators and the principal investigator's name. Significant details about the study's focus on Acute Myeloid Leukemia and related conditions remain, but extensive descriptions of the study's methodology and criteria have been removed.
    Difference
    40%
    Check dated 2025-04-16T20:19:20.000Z thumbnail image

Stay in the know with updates to SL-401 Combo in AML/MDS/BPDCN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SL-401 Combo in AML/MDS/BPDCN Clinical Trial page.